Total net assets ($CAD):
$81.66 million

Asset allocation

Geographic allocation

Sector allocation

The top 15 holdings make up 54.30% of the Fund.
Top holdings Sector allocation (%)
Eli Lilly and Co Drugs 9.75%
Johnson & Johnson Drugs 7.39%
AbbVie Inc Drugs 4.82%
Merck & Co Inc Drugs 3.77%
AstraZeneca PLC Drugs 3.64%
Roche Holding AG Drugs 3.60%
Novartis AG Cl N Drugs 3.58%
UnitedHealth Group Inc Healthcare Services 3.07%
Amgen Inc Drugs 2.37%
Thermo Fisher Scientific Inc Healthcare Equipment 2.32%
Abbott Laboratories Healthcare Equipment 2.23%
Gilead Sciences Inc Drugs 2.17%
Intuitive Surgical Inc Healthcare Equipment 2.04%
Pfizer Inc Drugs 2.00%
Bristol-Myers Squibb Co Drugs 1.55%